What a total debacle……it is the identical ‘flip side outcome’ to our Ryoncil situation. Such a pity that the Congressional Committee didn’t highlight our case as a comparison to Aduheim….,.ie a therapy that was actually effective & efficacious..,,,9-1 ODAC approved…..no existing SOC for young children …boxes galore all ticked……yet ‘talk to the hand’ from the FDA. Hopefully common sense & justice prevails in 2023.
What a total debacle……it is the identical ‘flip side outcome’ to...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
-0.010(0.69%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.50 | $1.43 | $4.048M | 2.778M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 26808 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 16001 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |